Ubs Oconnor LLC Iterum Therapeutics PLC Transaction History

Ubs Oconnor LLC

  • $1.72 Billion
  • Q2 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 13, 2020
SELL
$1.19 - $4.38 $809 - $2,978
-680 Reduced 0.77%
88,009 $104,000
Q2 2019

Aug 14, 2019
SELL
$6.09 - $9.1 $2,740 - $4,095
-450 Reduced 0.5%
88,689 $0
Q1 2019

May 13, 2019
SELL
$4.88 - $8.17 $48,180 - $80,662
-9,873 Reduced 9.97%
89,139 $0
Q4 2018

Feb 15, 2019
SELL
$5.01 - $7.9 $4,949 - $7,805
-988 Reduced 0.99%
99,012 $496,000
Q2 2018

Aug 14, 2018
BUY
$10.67 - $12.85 $1.07 Million - $1.29 Million
100,000 New
100,000 $0

Others Institutions Holding ITRM

# of Institutions
1
Shares Held
66
Call Options Held
0
Put Options Held
0
View Full List

About Iterum Therapeutics plc

ITRM Quotes by TradingView
  • Ticker ITRM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 12,233,400
  • Market Cap $15.9M
  • Description
  • Iterum Therapeutics plc, a clinical-stage pharmaceutical company, engages in developing and commercializing anti-infectives in Ireland, Bermuda, and the United States. It is developing sulopenem, a novel anti-infective compound with oral and IV formulations that is in Phase III clinical trials for the treatment of uncomplicated urinary tract inf...
More about ITRM
Track This Portfolio

Track Ubs Oconnor LLC Portfolio

Follow Ubs Oconnor LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Oconnor LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Oconnor LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email